CymitQuimica logo

CAS 66611-37-8

:

3-Pyridinecarboximidamide, N-[2-hydroxy-3-(1-piperidinyl)propoxy]-,dihydrochloride

Description:
3-Pyridinecarboximidamide, N-[2-hydroxy-3-(1-piperidinyl)propoxy]-, dihydrochloride, with CAS number 66611-37-8, is a chemical compound characterized by its complex structure, which includes a pyridine ring, an imidamide functional group, and a piperidine moiety. This compound typically appears as a white to off-white solid and is soluble in water due to the presence of the dihydrochloride salt form, which enhances its solubility and stability. The presence of the hydroxyl group contributes to its potential as a pharmacological agent, possibly influencing its interaction with biological systems. Its molecular structure suggests potential applications in medicinal chemistry, particularly in the development of therapeutic agents. The compound's properties, such as melting point, boiling point, and specific reactivity, would be influenced by its functional groups and overall molecular configuration. As with many chemical substances, safety data sheets should be consulted for handling and toxicity information, ensuring proper safety protocols are followed in laboratory settings.
Formula:C14H22N4O2・2ClH
InChI:InChI=1S/C14H22N4O2.2ClH/c15-14(12-5-4-6-16-9-12)17-20-11-13(19)10-18-7-2-1-3-8-18;;/h4-6,9,13,19H,1-3,7-8,10-11H2,(H2,15,17);2*1H
InChI key:ISGGVCWFTPTHIX-UHFFFAOYSA-N
SMILES:C1CCN(CC1)CC(CO/N=C(/C2=CN=CC=C2)\N)O.Cl.Cl
Found 8 products.
  • BGP-15 Hydrochloride

    CAS:
    Formula:C14H22N4O2·xHCl
    Purity:>98.0%(HPLC)
    Color and Shape:White to Light yellow powder to crystal

    Ref: 3B-B6160

    5mg
    80.00€
    25mg
    271.00€
  • BGP-15

    CAS:
    BGP-15
    Formula:C14H24Cl2N4O2
    Purity:99.5%
    Molecular weight:351.27

    Ref: 54-BUP10656

    5mg
    52.00€
    10mg
    75.00€
    25mg
    144.00€
    50mg
    225.00€
    100mg
    347.00€
    200mg
    500.00€
  • BGP-15

    CAS:
    Formula:C14H24Cl2N4O2
    Purity:95%
    Color and Shape:Solid
    Molecular weight:351.2720

    Ref: IN-DA006JN0

    1mg
    58.00€
    5mg
    82.00€
    10mg
    127.00€
    25mg
    199.00€
    50mg
    281.00€
    100mg
    543.00€
    250mg
    597.00€
    1g
    1,428.00€
  • BGP-15

    CAS:
    N-(2-Hydroxy-3-(piperidin-1-yl)propoxy)nicotinimidamide dihydrochloride
    Formula:C14H24Cl2N4O2
    Purity:95%
    Molecular weight:351.27
  • BGP-15

    CAS:
    BGP-15 (BGP-15 2HCl) is a PARP inhibitor with protecting effect after ischemia-reperfusion injury.
    Formula:C14H24Cl2N4O2
    Purity:98.17% - 99.99%
    Color and Shape:Yellow Solid
    Molecular weight:351.272
  • N-(2-Hydroxy-3-(piperidin-1-yl)propoxy)nicotinimidamide dihydrochloride

    CAS:
    Formula:C14H24Cl2N4O2
    Purity:95%
    Molecular weight:351.27

    Ref: 10-F235309

    1mg
    45.00€
    5mg
    86.00€
    10mg
    120.00€
    25mg
    223.00€
    50mg
    341.00€
    100mg
    561.00€
    250mg
    819.00€
    1g
    1,789.00€
  • BGP 15

    Controlled Product
    CAS:

    Applications BGP 15 is a calcipotriene-based vitamin D3 analog that inhibits poly(ADP-ribose) polymerasesis (PARP), a class of enzymes that regulate DNA repair and apoptosis (1). BGP 15 is also a cardioprotective agent (2). Also, BPG 15 improves mitochondrial function, protects neurons from dying in vitro and in vivo, and promotes cardiac innervation in vivo.
    References (1) Berkovich, L., et al.: Anticancer Drugs. 21, 609 (2010) (2) Szabados, E., et al. Biochem Pharmacol. 59, 937 (2000)

    Formula:C14H22N4O2·2HCl
    Color and Shape:Neat
    Molecular weight:351.27

    Ref: TR-B411990

    25mg
    237.00€
    100mg
    823.00€
    250mg
    1,670.00€
  • BGP-15

    CAS:
    BGP-15 is a mitochondria-targeted pharmacological agent that has been shown to improve cardiac function and reduce oxidative stress. BGP-15 is a peptide with reactive properties, which inhibits the production of reactive oxygen species (ROS) and increases mitochondrial membrane potential. These effects are mediated by activation of the cytochrome c oxidase pathway in the mitochondria, leading to increased energy metabolism and ATP production. BGP-15 has also been shown to reduce cardiomyocyte apoptosis and inhibit myocardial hypertrophy in vivo. The therapeutic potential of BGP-15 has been demonstrated in various models, including murine hepatoma cells, where it promotes caspase-independent cell death (apoptosis). This drug may have beneficial effects against infectious diseases such as tuberculosis or malaria, as well as autoimmune diseases such as rheumatoid arthritis.
    Formula:C14H24Cl2N4O2
    Purity:Min. 95%
    Molecular weight:351.27 g/mol

    Ref: 3D-RCA61137

    50mg
    950.00€
    100mg
    1,245.00€